PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment

Phase: PHASE1, PHASE2 | Sponsor: Johns Hopkins University | Compound: Psilocybin

Status

planned

Institution

Johns Hopkins University

Start date

2026-06-01

End date

2028-12-01

Registry ID

NCT07610135

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.